↓ Skip to main content

Oncotarget

Synergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma rodent models and is feasible for the treatment of canine malignant glioma patients

Overview of attention for article published in Oncotarget, July 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
6 news outlets
blogs
1 blog
twitter
6 X users
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
54 Mendeley